Zynerba Pharmaceuticals (ZYNE)

[iluvtofu]

Looks like the patent may have given us a big boost during these Coronavirus sell offs. Here's the article...

Zynerba Pharma Gets New Patent for Autism Spectrum Disorder Treatment

7:27 am ET February 25, 2020 (Dow Jones) Print
By Chris Wack

Zynerba Pharmaceuticals Inc. said Tuesday the U.S. Patent and Trademark Office has issued a patent titled "Treatment of Autism with Cannabidiol," which includes claims directed to methods of treating autism spectrum disorder by transdermally administering, via a gel or cream, a therapeutically effective amount of purified cannabidiol.

The company said the new patent expires in 2038.

Zynerba also said it has completed enrollment in the open label phase 2 study evaluating the safety, tolerability and efficacy of Zygel for the treatment of children and adolescents with autism spectrum disorder, with 37 patients enrolled. The company expects to report top line data from this trial in the second quarter of 2020.

Write to Chris Wack at [e-mail]

(END) Dow Jones Newswires

February 25, 2020 07:27 ET (12:27 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.